U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07586657) titled 'Precision Radiotherapy for Refractory Brain Metastases: A Multicenter Study' on April 09.
Brief Summary: Conventional image-guided techniques (such as cone-beam CT) have poor soft tissue contrast and unsatisfactory treatment outcomes. MRgART offers high-resolution imaging of brain tissue and, by acquiring daily MR images, successfully achieves real-time image monitoring, displaying tumor position and volume changes during treatment. This may improve local control rates for brain metastases, reduce toxicities, and translate into survival benefits. Our research team has already conducted a phase II prospective study and achieved favora...